Thelansis

Inherited retinal diseases (IRDs), also known as inherited retinal degeneration or retinal dystrophy, are caused by over 260 genes. IRDs have three inheritance patterns: autosomal dominant, autosomal recessive, and X-linked. IRDs affect various retinal cells and come in different types, including retinitis pigmentosa, rod dystrophy, Usher syndrome, Bietti crystalline dystrophy, Batten disease, Bardet-Biedl syndrome, Alport syndrome, Leber congenital amaurosis or early onset retinal dystrophy, cone dystrophy, cone-rod dystrophy, achromatopsia, congenital stationary night blindness, macula dystrophy, Stargardt’s disease, Best disease, pattern dystrophy, Sorsby fundus dystrophy, Doyne’s honeycomb dystrophy, choroideremia, and X-linked retinoschisis. Luxturna (Voretigene-Neparvovec), a gene therapy from Novartis, is the only approved treatment available for any IRD. ·        Inherited retinal diseases affect one in 4,000 people globally. Thelansis’s “Inherited ...

 Inherited retinal diseases (IRDs), also known as inherited retinal degeneration or retinal dystrophy, are caused by over 260 genes. IRDs have three inheritance patterns: autosomal dominant, autosomal recessive, and X-linked. IRDs affect various retinal cells and come in different types, including retinitis pigmentosa, rod dystrophy, Usher syndrome, Bietti crystalline dystrophy, Batten disease, Bardet-Biedl syndrome, Alport syndrome, Leber congenital amaurosis or early onset retinal dystrophy, cone dystrophy, cone-rod dystrophy, achromatopsia, congenital stationary night blindness, macula dystrophy, Stargardt’s disease, Best disease, pattern dystrophy, Sorsby fundus dystrophy, Doyne’s honeycomb dystrophy, choroideremia, and X-linked retinoschisis. Luxturna (Voretigene-Neparvovec), a gene therapy from Novartis, is the only approved treatment available for any IRD. ·        Inherited retinal diseases affect one in 4,000 people globally. Thelansis’s “...